Roadmap on Universal Photonic Biosensors for Real-Time Detection of Emerging Pathogens

Photonics

Morgan G. Blevins¹  Milo J. Hooper²  Svetlana V. Boriskina²  Alvaro Fernandez-Galiana² 

[1] Department of Aeronautics and Astronautics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA;Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA;

关键词: biosensors;    pathogen detection;    rapid sensing;    optical amplification;    point-of-care testing;   

DOI  :  10.3390/photonics8080342

来源: DOAJ

【 摘 要 】

The COVID-19 pandemic has made it abundantly clear that the state-of-the-art biosensors may not be adequate for providing a tool for rapid mass testing and population screening in response to newly emerging pathogens. The main limitations of the conventional techniques are their dependency on virus-specific receptors and reagents that need to be custom-developed for each recently-emerged pathogen, the time required for this development as well as for sample preparation and detection, the need for biological amplification, which can increase false positive outcomes, and the cost and size of the necessary equipment. Thus, new platform technologies that can be readily modified as soon as new pathogens are detected, sequenced, and characterized are needed to enable rapid deployment and mass distribution of biosensors. This need can be addressed by the development of adaptive, multiplexed, and affordable sensing technologies that can avoid the conventional biological amplification step, make use of the optical and/or electrical signal amplification, and shorten both the preliminary development and the point-of-care testing time frames. We provide a comparative review of the existing and emergent photonic biosensing techniques by matching them to the above criteria and capabilities of preventing the spread of the next global pandemic.

【 授权许可】

Unknown